2. Conclusions Comorbidity and its treatment appear to be an important influence on the
behavior of cancer in older patients. Rather than a blanket effect, this may be attached to …

I would like to take this opportunity to thank the people who have helped me in the
completion of this work. I could not have done it without them. I want to acknowledge my …

Невідємною властивістю підвищення результативності медичної науки є її постійний і
невпинний розвиток. Він в першу чергу передбачає впровадження в клінічну практику …

Відомо, що глюкозамінілмурамілдипептид (ГМДП), який відноситься до
фармакотерапевтичної групи: цитокіни та імуностимулятори (код АТС LO3А), що також …

Introduction: Colorectal carcinoma is the commonest gastrointestinal malignancy and one of
the most common cancers worldwide. Colorectal carcinoma does not have any early signs …

Objective: The objective of this project is to evaluate the chemoprevention efficacy of locally
bioavailable and selective COX-2 inhibitor 6a1 by using Pirc rat model with DSS …

Celecoxib (C), a COX-2 enzyme inhibitor, was administered at a 0.1% dose level in the diet
of female Swiss Webster CFW outbred mice for life. The mice also received 1, 2 …

Se realizó un estudio prospectivo de casos y controles de base hospitalaria para estimar el
riesgo de padecer cáncer colorrectal en función de diversos factores ambientales, entre los …

In this serial sacrifice experiment, celecoxib (C) was administered at a 0.1% dose level, in
the diet of female Swiss Webster CFW outbred mice. The animals also received either 1, 2 …

The present study is an attempt to synthesize nanosized guar gum carriers encapsulating
celecoxib as the chemopreventive agent for experimental colorectal cancer (CRC). Guar …